Loading…

Adding metyrapone to chemotherapy plus mitotane for Cushing’s syndrome due to advanced adrenocortical carcinoma

Saved in:

Bibliographic Details
Published in:	Endocrine 2018-07, Vol.61 (1), p.169-172
Main Authors:	Claps, Mélanie, Cerri, Sara, Grisanti, Salvatore, Lazzari, Barbara, Ferrari, Vittorio, Roca, Elisa, Perotti, Paola, Terzolo, Massimo, Sigala, Sandra, Berruti, Alfredo
Format:	Article
Language:	English
Subjects:	Adrenal Cortex Neoplasms - complications Adrenocortical Carcinoma - complications Adrenocorticotropic hormone Adult Aged Antimetabolites, Antineoplastic - therapeutic use Antineoplastic Agents, Hormonal - therapeutic use Chemotherapy Cushing syndrome Cushing Syndrome - drug therapy Cushing Syndrome - etiology Diabetes Drug Therapy, Combination Endocrinology Feasibility Studies Humanities and Social Sciences Humans Hydrocortisone - urine Internal Medicine Male Medicine Medicine & Public Health Metyrapone - therapeutic use Middle Aged Mitotane - therapeutic use multidisciplinary Nervous system diseases Pituitary Research Letter Science Treatment Outcome
Citations:	Items that this one cites Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!